publication venue for
- A Mutation-Independent CRISPR/Cas9-Based `Knockout and Replace' Strategy to Treat Rhodopsin-Associated Autosomal Dominant Retinitis Pigmentosa 2022
- Economic Analysis and Cost Optimization of Adenovirus Purification Processes 2021
- Development and Scale-Up of a Monolithic Chromatography Purification Method for Rhabdoviral Vectors 2020
- Chromatography Purification Methods for Rhabdoviral Vectors 2019
- Editing Aberrant Splice Sites with Cas9 and Cas12a Efficiently Restores beta-Globin Expression in beta-Thalassemia 2019
- coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia 2019
- Optimization of a Monolithic Chromatography-Based Manufacturing Process for Adenoviral Vectors 2018
- Development of a Monolithic Chromatography-Based Manufacturing Process for Clinical-Grade Viral Vectors 2017
- 66. Recombinant Newcastle Disease Virus as an Oncolytic Therapy for Ovarian and Prostate Cancers 2016
- 713. Optimization and Scale-Up of a Manufacturing Process for Clinical-Grade Adenovirus-Based Vectors 2016
- Pre-Clinical Patient Cell Mobilizations and Transduction Outcomes in Preparation for a Clinical Trial Application of Lentivirus-Mediated Gene Therapy for Fabry Disease 2014
- Large-Scale Production of a Maraba-Based Oncolytic Virus 2012
- 1085. In Vivo Imaging of Microencapsulated Gene Therapy 2006
- 316. Production of Adenoviral Vectors in an Academic cGMP Facility 2006
- Downregulation of immune responses induced by oral DNA administration 2004
- Partial correction of the hemophilic phenotype in mice implanted with encapsulated human primary myoblasts secreting FIX 2004
- Combined immunotherapy and anti-angiogenic therapy of cancer delivered by genetically engineered non-autologous microencapsulated cells 2003
- Isolation and identification of mammaglobin gene upstream region (25.4 kb) using helper-dependent adenoviral vectors 2003
- MRI-visible microcapsules for gene therapy 2003
- Oral administration of plasmid DNA results in targeted gene expression and sustained disease correction 2003
- Somatic gene therapy of mucopolysaccharidosis type II by encapsulated recombinant myoblasts 2003
- Therapy of human prostate and breast carcinoma in experimental models by redirected effector lymphocytes expressing Erb-B2 specific chimeric receptors 2003
- Eliminating Panglossian thinking in development of AAV therapeutics. 29:3325-3327. 2021
- Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque. 27:1074-1086. 2019
- Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α. 25:1199-1208. 2017
- T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice. 23:1600-1610. 2015
- Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease. 22:1320-1332. 2014
- Maraba Virus as a Potent Oncolytic Vaccine Vector. 22:420-429. 2014
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies. 22:251-256. 2014
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses. 22:233-238. 2014
- Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy. 22:123-131. 2014
- Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor. 22:206-218. 2014
- Panorama From the Oncolytic Virotherapy Summit. 21:1814-1818. 2013
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy. 21:887-894. 2013
- Gene Therapy for Hemophilia: Addressing the Coming Challenges of Affordability and Accessibility. 21:1-2. 2013
- Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine. 20:1791-1799. 2012
- ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic. 20:1148-1157. 2012
- Combined mTOR Inhibition and OX40 Agonism Enhances CD8+ T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines. 20:860-869. 2012
- Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.. 20:860-869. 2012
- Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia. 19:1749-1750. 2011
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy. 19:841-853. 2011
- Targeting Tumor Vasculature With an Oncolytic Virus. 19:886-894. 2011
- Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy. 19:335-344. 2011
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus. 18:1430-1439. 2010
- Recognition of Virus Infection and Innate Host Responses to Viral Gene Therapy Vectors. 18:1422-1429. 2010
- FimH Can Directly Activate Human and Murine Natural Killer Cells via TLR4. 18:1379-1388. 2010
- A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers. 18:1123-1129. 2010
- A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.. 18:1123-1129. 2010
- Processing of Tumor Antigen Differentially Impacts the Development of Helper and Effector CD4+ T-cell Responses. 18:1224-1232. 2010
- Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing. 18:888-895. 2010
- Intelligent Design: Combination Therapy With Oncolytic Viruses. 18:251-263. 2010
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus. 17:1814-1821. 2009
- Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity. 17:1465-1472. 2009
- Immunization With a Bivalent Adenovirus-vectored Tuberculosis Vaccine Provides Markedly Improved Protection Over Its Monovalent Counterpart Against Pulmonary Tuberculosis. 17:1093-1100. 2009
- A let-7 MicroRNA-sensitive Vesicular Stomatitis Virus Demonstrates Tumor-specific Replication. 16:1437-1443. 2008
- Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus–vectored Tuberculosis Vaccine. 16:1161-1169. 2008
- Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2. 16:607-617. 2008
- Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells. 16:411-418. 2008
- Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells.. 16:411-418. 2008
- On the Role of CD4+ T Cells in the CD8+ T-Cell Response Elicited by Recombinant Adenovirus Vaccines. 15:997-1006. 2007
- On the role of CD4(+) T cells in the CD8(+) T-cell response elicited by recombinant adenovirus vaccines. 15:997-1006. 2007
- Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity. 15:123-130. 2007
- Development of Cell-Based Tuberculosis Vaccines: Genetically Modified Dendritic Cell Vaccine Is a Much More Potent Activator of CD4 and CD8 T Cells Than Peptide- or Protein-Loaded Counterparts. 13:766-775. 2006
- Optimizing Plasmid-Based Gene Transfer for Investigating Skeletal Muscle Structure and Function. 13:795-803. 2006
- Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia. 13:270-279. 2006
- The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma. 12:1101-1110. 2005
- High-Resolution Imaging of Bone Precursor Cells Within the Intact Bone Marrow Cavity of Living Mice. 12:33-41. 2005
- High-resolution imaging of bone precursor cells within the intact bone marrow cavity of living mice.. 12:33-41. 2005
- Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45negPFV hemogenic precursors. 10:1109-1120. 2004
- The human SCGB2A2 (Mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells. 10:758-767. 2004
- Accelerated Wound Healing by In vivo Application of Keratinocytes Overexpressing KGF. 10:86-96. 2004
- Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. 8:777-789. 2003
- Characterization of Retroviral Gene Transfer into Highly Purified Human CD34− Cells with Primitive Hematopoietic Capacity. 5:635-643. 2002
- Development of a FLP/frt System for Generating Helper-Dependent Adenoviral Vectors. 3:809-815. 2001